Salvando as mosquinhas de fruta do mal de Alzheimer

sábado, julho 17, 2010

Rescuing Fruit Flies from Alzheimer's Disease

ScienceDaily (July 16, 2010) — Investigators have found that fruit fly (Drosophila melanogaster) males -- in which the activity of an Alzheimer's disease protein is reduced by 50 percent -- show impairments in learning and memory as they age. What's more, the researchers were able to prevent the age-related deficits by treating the flies with drugs such as lithium, or by genetic manipulations that reduced nerve-cell signaling.

In the example shown in still image from a video, a female fruit fly is receptive to his courtship, keeping him interested and ending with mating. If the female had not been receptive she would release less attractive pheromones and would have more aggressively discouraged the male to court her. Under these conditions, the male will quickly learn to not court females and will remember this for several hours. This ability to train males to learn and remember with courtship behavior was used to test for learning and memory defects in a fly model for familial Alzheimer's disease. (Credit: Thomas A. Jongens, PhD, University of Pennsylvania School of Medicine)

The research team -- Thomas A. Jongens, Ph.D., associate professor of Genetics at the University of Pennsylvania School of Medicine; Sean M. J. McBride M.D, Ph.D. and Thomas McDonald M.D., at the Albert Einstein College of Medicine; and Catherine Choi M.D., Ph.D. at Drexel University College of Medicine -- worked with the familial form of Alzheimer's disease (FAD), an aggressive form of the disease that is caused by mutations in one of the two copies of the presenilin (PS) oramyloid precursor protein (APP) genes. Studies in animal models have previously shown that the FAD-linked PS mutations lead to less presenilin (psn) protein activity.

Their findings are published in theJournal of Neuroscience.

"The results from our study suggest a new route to explore for the treatment of familial Alzheimer's disease and possibly the more common sporadic forms of Alzheimer's disease," notes Jongens. "They also reveal that proper presenilin activity levels are required to maintain normal cognitive capabilities during aging."
...

Read more/Leia mais aqui: Science Daily

+++++

Neurobiology of Disease

Journal of Neuroscience, 2010; 30: 9510-9522

Pharmacological and Genetic Reversal of Age-Dependent Cognitive Deficits Attributable to Decreased presenilin Function

Sean M. J. McBride,1,2 * Catherine H. Choi,1,2,3 * Brian P. Schoenfeld,1,2 * Aaron J. Bell,1,2 David A. Liebelt,1,2 David Ferreiro,1,2Richard J. Choi,1,2 Paul Hinchey,1,2 Maria Kollaros,1,2 Allison M. Terlizzi,1,2 Neal J. Ferrick,1,2 Eric Koenigsberg,1,2 Rebecca L. Rudominer,1,2Ai Sumida,4 Stephanie Chiorean,4 Kathleen K. Siwicki,5 Hanh T. Nguyen,1,2 Mark E. Fortini,6 Thomas V. McDonald,1,2 and Thomas A. Jongens4 

1Section of Molecular Cardiology and 2Departments of Medicine and Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York 10461,3Department of Dermatology, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102, 4Department of Genetics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, 5Department of Biology, Swarthmore College, Swarthmore, Pennsylvania 19081, and 6Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107

Correspondence should be addressed to any of the following: Sean M. J. McBride, c/o Thomas McDonald Lab, Section of Molecular Cardiology and Department of Molecular Pharmacology, Albert Einstein College of Medicine, Forchheimer G35, 1300 Morris Park Avenue, Bronx, NY 10461, Email: smcbride@aecom.yu.edu; Thomas McDonald, Section of Molecular Cardiology and Department of Molecular Pharmacology, Albert Einstein College of Medicine, Forchheimer G35, 1300 Morris Park Avenue, Bronx, NY 10461, E-mail: Email: mcdonald@aecom.yu.edu; or Thomas A. Jongens, Department of Genetics, University of Pennsylvania, School of Medicine, 538A CRB, 415 Curie Boulevard, Philadelphia, PA 19104, E-mail: Email: jongens@mail.med.upenn.edu

Abstract
Alzheimer's disease (AD) is the leading cause of cognitive loss and neurodegeneration in the developed world. Although its genetic and environmental causes are not generally known, familial forms of the disease (FAD) are attributable to mutations in a single copy of the Presenilin (PS) and amyloid precursor protein genes. The dominant inheritance pattern of FAD indicates that it may be attributable to gain or change of function mutations. Studies of FAD-linked forms of presenilin (psn) in model organisms, however, indicate that they are loss of function, leading to the possibility that a reduction in PS activity might contribute to FAD and that proper psn levels are important for maintaining normal cognition throughout life. To explore this issue further, we have tested the effect of reducing psn activity during aging in Drosophila melanogaster males. We have found that flies in which the dosage of psn function is reduced by 50% display age-onset impairments in learning and memory. Treatment with metabotropic glutamate receptor (mGluR) antagonists or lithium during the aging process prevented the onset of these deficits, and treatment of aged flies reversed the age-dependent deficits. Genetic reduction of Drosophila metabotropic glutamate receptor (DmGluRA), the inositol trisphosphate receptor (InsP3R), or inositol polyphosphate 1-phosphatase also prevented these age-onset cognitive deficits. These findings suggest that reduced psn activity may contribute to the age-onset cognitive loss observed with FAD. They also indicate that enhanced mGluR signaling and calcium release regulated by InsP3R as underlying causes of the age-dependent cognitive phenotypes observed when psn activity is reduced.


Received Feb. 25, 2010; revised March 31, 2010; accepted June 1, 2010.
Correspondence should be addressed to any of the following: Sean M. J. McBride, c/o Thomas McDonald Lab, Section of Molecular Cardiology and Department of Molecular Pharmacology, Albert Einstein College of Medicine, Forchheimer G35, 1300 Morris Park Avenue, Bronx, NY 10461, Email: smcbride@aecom.yu.edu; Thomas McDonald, Section of Molecular Cardiology and Department of Molecular Pharmacology, Albert Einstein College of Medicine, Forchheimer G35, 1300 Morris Park Avenue, Bronx, NY 10461, E-mail: Email: mcdonald@aecom.yu.edu; or Thomas A. Jongens, Department of Genetics, University of Pennsylvania, School of Medicine, 538A CRB, 415 Curie Boulevard, Philadelphia, PA 19104, E-mail: Email: jongens@mail.med.upenn.edu

+++++


+++++

Vote neste blog para o prêmio TOPBLOG 2010.